967 related articles for article (PubMed ID: 30842125)
21.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
22. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
[TBL] [Abstract][Full Text] [Related]
23. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers.
Ramtohul T; Djerroudi L; Lissavalid E; Nhy C; Redon L; Ikni L; Djelouah M; Journo G; Menet E; Cabel L; Malhaire C; Tardivon A
Radiology; 2023 Aug; 308(2):e222646. PubMed ID: 37526540
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging.
Parekh VS; Jacobs MA
Breast Cancer Res Treat; 2020 Apr; 180(2):407-421. PubMed ID: 32020435
[TBL] [Abstract][Full Text] [Related]
25. Use of Pretreatment Multiparametric MRI to Predict Tumor Regression Pattern to Neoadjuvant Chemotherapy in Breast Cancer.
Liu C; Huang X; Chen X; Shi Z; Liu C; Liang Y; Huang X; Chen M; Chen X; Liang C; Liu Z
Acad Radiol; 2023 Sep; 30 Suppl 2():S62-S70. PubMed ID: 37019697
[TBL] [Abstract][Full Text] [Related]
26. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
Bickelhaupt S; Paech D; Kickingereder P; Steudle F; Lederer W; Daniel H; Götz M; Gählert N; Tichy D; Wiesenfarth M; Laun FB; Maier-Hein KH; Schlemmer HP; Bonekamp D
J Magn Reson Imaging; 2017 Aug; 46(2):604-616. PubMed ID: 28152264
[TBL] [Abstract][Full Text] [Related]
27. Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.
Sun C; Tian X; Liu Z; Li W; Li P; Chen J; Zhang W; Fang Z; Du P; Duan H; Liu P; Wang L; Chen C; Tian J
EBioMedicine; 2019 Aug; 46():160-169. PubMed ID: 31395503
[TBL] [Abstract][Full Text] [Related]
28. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
Sang L; Liu Z; Huang C; Xu J; Wang H
Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer.
Cheng Y; Luo Y; Hu Y; Zhang Z; Wang X; Yu Q; Liu G; Cui E; Yu T; Jiang X
Abdom Radiol (NY); 2021 Nov; 46(11):5072-5085. PubMed ID: 34302510
[TBL] [Abstract][Full Text] [Related]
31. Radiomic Features of Primary Rectal Cancers on Baseline T
Antunes JT; Ofshteyn A; Bera K; Wang EY; Brady JT; Willis JE; Friedman KA; Marderstein EL; Kalady MF; Stein SL; Purysko AS; Paspulati R; Gollamudi J; Madabhushi A; Viswanath SE
J Magn Reson Imaging; 2020 Nov; 52(5):1531-1541. PubMed ID: 32216127
[TBL] [Abstract][Full Text] [Related]
32. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract][Full Text] [Related]
33. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
[TBL] [Abstract][Full Text] [Related]
34. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer.
Bitencourt AGV; Gibbs P; Rossi Saccarelli C; Daimiel I; Lo Gullo R; Fox MJ; Thakur S; Pinker K; Morris EA; Morrow M; Jochelson MS
EBioMedicine; 2020 Nov; 61():103042. PubMed ID: 33039708
[TBL] [Abstract][Full Text] [Related]
35. Machine learning-based radiomics analysis in predicting the meningioma grade using multiparametric MRI.
Hu J; Zhao Y; Li M; Liu J; Wang F; Weng Q; Wang X; Cao D
Eur J Radiol; 2020 Oct; 131():109251. PubMed ID: 32916409
[TBL] [Abstract][Full Text] [Related]
36. A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
Sutton EJ; Onishi N; Fehr DA; Dashevsky BZ; Sadinski M; Pinker K; Martinez DF; Brogi E; Braunstein L; Razavi P; El-Tamer M; Sacchini V; Deasy JO; Morris EA; Veeraraghavan H
Breast Cancer Res; 2020 May; 22(1):57. PubMed ID: 32466777
[TBL] [Abstract][Full Text] [Related]
37. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
[TBL] [Abstract][Full Text] [Related]
38. Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma.
Wang H; Song B; Ye N; Ren J; Sun X; Dai Z; Zhang Y; Chen BT
Eur J Radiol; 2020 Jan; 122():108755. PubMed ID: 31783344
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancer.
Yang Y; Li J; Liu Y; Zhong Y; Ren W; Tan Y; He Z; Li C; Ouyang J; Hu Q; Yu Y; Yao H
Breast; 2021 Dec; 60():90-97. PubMed ID: 34536884
[TBL] [Abstract][Full Text] [Related]
40. Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI.
Caballo M; Sanderink WBG; Han L; Gao Y; Athanasiou A; Mann RM
J Magn Reson Imaging; 2023 Jan; 57(1):97-110. PubMed ID: 35633290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
